Global Cancer Biopsy Market Size Study by Type, Application, Product, and Regional Forecasts 2022-2032

Global Cancer Biopsy Market Size Study by Type, Application, Product, and Regional Forecasts 2022-2032

The Global Cancer Biopsy Market, valued at approximately USD 30.05 billion in 2023, is poised to ascend to a staggering USD 60.62 billion by 2032, showcasing a robust compound annual growth rate (CAGR) of 8.11% during the forecast period from 2024 to 2032. This remarkable growth trajectory is underpinned by the escalating demand for non-invasive diagnostic tools and the rising prevalence of cancer worldwide. Cancer biopsy techniques, such as liquid biopsies and core needle biopsies, have revolutionized oncology by enabling precise, early-stage cancer detection and facilitating personalized treatment approaches.

Liquid biopsies, celebrated for their minimally invasive nature, have gained substantial traction in recent years. These innovative diagnostic tools, capable of detecting circulating tumor cells (CTCs) and cell-free DNA (cfDNA) in blood, offer clinicians a dynamic and comprehensive view of the tumor’s molecular landscape. Complementing this, core needle biopsies remain a gold standard for obtaining tissue samples in cases where detailed histopathological analysis is required. Together, these techniques are redefining the paradigm of cancer diagnosis and monitoring, empowering healthcare professionals to make informed clinical decisions.

The market’s growth is further propelled by technological advancements in biopsy instruments and kits, which have enhanced the accuracy, efficiency, and patient comfort associated with cancer diagnosis. Investments in R&D by leading market players, coupled with supportive government initiatives aimed at bolstering cancer screening programs, are significantly contributing to the market's expansion. However, high procedural costs and limited access to advanced biopsy technologies in emerging economies remain key challenges.

Regionally, North America dominates the Cancer Biopsy Market, driven by its robust healthcare infrastructure, significant investments in cancer research, and widespread adoption of advanced diagnostic tools. Europe follows suit, with strong government support and an increasing focus on early detection and precision medicine. The Asia Pacific region is anticipated to witness the fastest growth, fueled by rising healthcare expenditure, improving cancer awareness, and the burgeoning adoption of innovative diagnostic technologies in countries like China and India. Meanwhile, Latin America and the Middle East & Africa present lucrative opportunities, underpinned by improving healthcare access and rising investments in oncology diagnostics.

Major market players included in this report are:
• QIAGEN
• Thermo Fisher Scientific
• Biocept, Inc.
• Guardant Health, Inc.
• Roche Diagnostics
• Illumina, Inc.
• Bio-Rad Laboratories
• Myriad Genetics, Inc.
• Agilent Technologies
• F. Hoffmann-La Roche Ltd
• Menarini Silicon Biosystems
• Genomic Health
• Hologic, Inc.
• Sysmex Corporation
• Oxford Gene Technology

The detailed segments and sub-segments of the market are explained below:

By Type:
• Liquid Biopsy
• Core Needle Biopsy

By Application:
• Breast Cancer
• Lung Cancer

By Product:
• Kits & Consumables
• Instruments

By Region:

North America:
• U.S.
• Canada

Europe:
• UK
• Germany
• France
• Spain
• Italy
• Rest of Europe

Asia Pacific:
• China
• India
• Japan
• Australia
• South Korea
• Rest of Asia Pacific

Latin America:
• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa:
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional-level analysis for each market segment.
• Comprehensive analysis of the geographical landscape with country-level insights across major regions.
• Competitive landscape featuring detailed profiles and strategies of major market players.
• Analysis of key business strategies and recommendations for future market approaches.
• Comprehensive analysis of the competitive structure of the market.
• Demand-side and supply-side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.